Publication | Open Access

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

Biomarker (Medicine)Prognostic BiomarkersOncologyProtein BiomarkersMedicineCorrect TrialBiomarker TargetPathologyColorectal CancerMetastatic Colorectal CancerBiomarker TestingMolecular DiagnosticsRadiation OncologyCancer Research